Epsom Day Surgery Limited Filleted accounts for Companies House (small and micro)

COMPANY REGISTRATION NUMBER: 05401512

Epsom Day Surgery Limited

Filleted Financial Statements

31 March 2025

Epsom Day Surgery Limited

Statement of Financial Position

31 March 2025

	2025		2024
Note	£	£	£

Fixed assets

Tangible assets	5		117,339	112,422

Current assets

Stocks		62,072	59,097
Debtors	6	1,500,713	1,432,382
Cash at bank and in hand		403,909	244,458
		------------	------------
		1,966,694	1,735,937

Creditors: amounts falling due within one year	7	707,696		613,532
		------------		------------
Net current assets			1,258,998	1,122,405
			------------	------------
Total assets less current liabilities			1,376,337	1,234,827
			------------	------------
Net assets			1,376,337	1,234,827
			------------	------------

Capital and reserves

Called up share capital	100,000	100,000
Profit and loss account	1,276,337	1,134,827
	------------	------------
Shareholders funds	1,376,337	1,234,827
	------------	------------

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of income and retained earnings has not been delivered.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

These financial statements were approved by the board of directors and authorised for issue on 16 December 2025 , and are signed on behalf of the board by:

Ms A R Pearce

Director

Company registration number: 05401512

Epsom Day Surgery Limited

Notes to the Financial Statements

Year ended 31 March 2025

1. General information

The company is a private company limited by shares, registered in England and Wales. The address of the registered office is Cobham Hospital, 168 Portsmouth Road, Cobham, Surrey, KT11 1HS.

2. Statement of compliance

These financial statements have been prepared in compliance with Section 1A of FRS 102, 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland'.

3. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Judgements and key sources of estimation uncertainty

The preparation of the financial statements requires management to make judgements, estimates and assumptions that affect the amounts reported. These estimates and judgements are continually reviewed and are based on experience and other factors, including expectations of future events that are believed to be reasonable under the circumstances.

Revenue recognition

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax. Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Income tax

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in profit or loss, except to the extent that it relates to items recognised in other comprehensive income or directly in equity. In this case, tax is recognised in other comprehensive income or directly in equity, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are initially recorded at cost, and subsequently stated at cost less any accumulated depreciation and impairment losses. Any tangible assets carried at revalued amounts are recorded at the fair value at the date of revaluation less any subsequent accumulated depreciation and subsequent accumulated impairment losses. An increase in the carrying amount of an asset as a result of a revaluation, is recognised in other comprehensive income and accumulated in equity, except to the extent it reverses a revaluation decrease of the same asset previously recognised in profit or loss. A decrease in the carrying amount of an asset as a result of revaluation, is recognised in other comprehensive income to the extent of any previously recognised revaluation increase accumulated in equity in respect of that asset. Where a revaluation decrease exceeds the accumulated revaluation gains accumulated in equity in respect of that asset, the excess shall be recognised in profit or loss.

Depreciation

Depreciation is calculated so as to write off the cost or valuation of an asset, less its residual value, over the useful economic life of that asset as follows:

Leasehold improvements	-	Over the remaining period of the lease
Fixtures and fittings	-	10/20% Straight line
Equipment	-	`10/20/33% Straight line`

Impairment of fixed assets

A review for indicators of impairment is carried out at each reporting date, with the recoverable amount being estimated where such indicators exist. Where the carrying value exceeds the recoverable amount, the asset is impaired accordingly. Prior impairments are also reviewed for possible reversal at each reporting date. For the purposes of impairment testing, when it is not possible to estimate the recoverable amount of an individual asset, an estimate is made of the recoverable amount of the cash-generating unit to which the asset belongs. The cash-generating unit is the smallest identifiable group of assets that includes the asset and generates cash inflows that largely independent of the cash inflows from other assets or groups of assets. For impairment testing of goodwill, the goodwill acquired in a business combination is, from the acquisition date, allocated to each of the cash-generating units that are expected to benefit from the synergies of the combination, irrespective of whether other assets or liabilities of the company are assigned to those units.

Stocks

Stocks are measured at the lower of cost and estimated selling price less costs to complete and sell. Cost includes all costs of purchase, costs of conversion and other costs incurred in bringing the stock to its present location and condition.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as either financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Defined contribution plans

Contributions to defined contribution plans are recognised as an expense in the period in which the related service is provided. Prepaid contributions are recognised as an asset to the extent that the prepayment will lead to a reduction in future payments or a cash refund. When contributions are not expected to be settled wholly within 12 months of the end of the reporting date in which the employees render the related service, the liability is measured on a discounted present value basis. The unwinding of the discount is recognised as a finance cost in profit or loss in the period in which it arises.

4. Employee numbers

The average number of persons employed by the company during the year amounted to 36 (2024: 32 ).

5. Tangible assets

	Land and buildings	Fixtures and fittings	Equipment	Total
	£	£	£	£
Cost
At 1 April 2024	310,119	95,528	648,616	1,054,263
Additions	25,254	–	30,550	55,804
	---------	--------	---------	------------
At 31 March 2025	335,373	95,528	679,166	1,110,067
	---------	--------	---------	------------
Depreciation
At 1 April 2024	294,436	93,638	553,767	941,841
Charge for the year	2,798	1,150	46,939	50,887
	---------	--------	---------	------------
At 31 March 2025	297,234	94,788	600,706	992,728
	---------	--------	---------	------------
Carrying amount
At 31 March 2025	38,139	740	78,460	117,339
	---------	--------	---------	------------
At 31 March 2024	15,683	1,890	94,849	112,422
	---------	--------	---------	------------

6. Debtors

	2025	2024
	£	£
Trade debtors	165,246	113,858
Amounts owed by group undertakings and undertakings in which the company has a participating interest	1,221,309	1,231,058
Other debtors	114,158	87,466
	------------	------------
	1,500,713	1,432,382
	------------	------------

The amounts due from group undertakings are due on demand.

7. Creditors: amounts falling due within one year

	2025	2024
	£	£
Trade creditors	138,551	126,735
Amounts owed to group undertakings and undertakings in which the company has a participating interest	323,123	319,471
Corporation tax	73,339	79,024
Other creditors	172,683	88,302
	---------	---------
	707,696	613,532
	---------	---------

The amounts due to group undertakings are due on demand.

8. Operating leases

The total future minimum lease payments under non-cancellable operating leases are as follows:

	2025	2024
	£	£
Not later than 1 year	164,124	164,038
Later than 1 year and not later than 5 years	443,159	440,330
Later than 5 years	944,167	1,054,167
	------------	------------
	1,551,450	1,658,535
	------------	------------

9. Summary audit opinion

The auditor's report dated 16 December 2025 was unqualified .

The senior statutory auditor was Christopher Cook BA FCA , for and on behalf of Cook & Co Accountants LLP .

10. Related party transactions

The company is a wholly owned subsidiary of Epsomedical Limited, which in turn is a wholly owned subsidiary of Epsomedical (Acquisitions) Limited. On 29th October 2024 Epsomedical (Acquisitions) Limited became a wholly owned subsidiary of Epsomedical Holdings Limited, a company in which Ms A R Pearce is the controlling shareholder. All the Companies are Registered in England and Wales. Mr T Taylor was a director of Epsomedical (Acquisitions) Limited until 30th October 2024 and a shareholder until 29th October 2024. He was also a director of Epsomedical Limited and Cobham Day Surgery Limited, which is also a wholly owned subsidiary of Epsomedical Limited until 29th October 2024. Dr M R Sevenoaks was a shareholder of Epsomedical (Acquisitions) Limited until 29th October 2024. During the year the company made sales to Integrated Care Partnership of £4,934 (2024: £15,106) and purchases of £65,899 (2024 £131,735), a partnership in which Dr M R Sevenoaks is a partner. During the year the company made sales to Cobham Day Surgery Limited of £150,865 (2024: £149,763) and purchases of £1,822,082 (2024: £1,324,502). During the year the company sold goods and services to Epsomedical Limited of £3,831,077 (2024: £3,723,172). At 31st March 2025 the company was owed the following amounts: Epsomedical (Acquisitions) Ltd £NIL (2024 - £820,000) Epsomedical Limited £149,309 (2024 - £411,058) Epsomedical Holdings Limited £1,072,000 (2024 - £Nil) At 31st March 2025 the company owed the following amounts: Cobham Day Surgery Limited £323,123 (2024 - £319,471)

11. Controlling party

The ultimate parent undertaking of the company was Epsomedical (Acquisitions) Limited until 29th October 2024, after which Epsomedical Holdings Limited became the ultimate parent undertaking. Both companies are registered in England and Wales.